0000014272-14-000048.txt : 20140206
0000014272-14-000048.hdr.sgml : 20140206
20140206172853
ACCESSION NUMBER: 0000014272-14-000048
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140206
FILED AS OF DATE: 20140206
DATE AS OF CHANGE: 20140206
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO
CENTRAL INDEX KEY: 0000014272
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 220790350
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
BUSINESS PHONE: 2125464000
MAIL ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
FORMER COMPANY:
FORMER CONFORMED NAME: BRISTOL MYERS CO
DATE OF NAME CHANGE: 19891012
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Caldarella Joseph C
CENTRAL INDEX KEY: 0001341069
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-01136
FILM NUMBER: 14581144
MAIL ADDRESS:
STREET 1: BRISTOL-MYERS SQUIBB COMPANY
STREET 2: RT 206 & PROVINCELINE ROAD
CITY: PRINCETON
STATE: NJ
ZIP: 08540
4
1
wf-form4_139172572240390.xml
FORM 4
X0306
4
2014-02-06
0
0000014272
BRISTOL MYERS SQUIBB CO
BMY
0001341069
Caldarella Joseph C
BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVENUE
NEW YORK
NY
10154
0
1
0
0
SVP & Controller
Common Stock, $0.10 par value
2014-02-06
4
M
0
10900
22.14
A
79242
D
Common Stock, $0.10 par value
2014-02-06
4
M
0
15584
17.51
A
94826
D
Common Stock, $0.10 par value
2014-02-06
4
S
0
35471
48.8979
D
59355
D
Option (right to buy)
22.14
2014-02-06
4
M
0
10900
0
D
2018-03-03
Common Stock, $0.10 par value
10900.0
0
D
Option (right to buy)
17.51
2014-02-06
4
M
0
15584
0
D
2019-03-02
Common Stock, $0.10 par value
15584.0
35000
D
The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $48.87 to $48.94, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 4, 2008.
Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 3, 2009.
/s/ Robert J. Wollin, attorney-in-fact for Joseph C. Caldarella
2014-02-06